139 related articles for article (PubMed ID: 14611674)
1. High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) prostate carcinogenesis.
Inaguma S; Takahashi S; Ohnishi H; Suzuki S; Cho YM; Shirai T
Cancer Sci; 2003 Nov; 94(11):974-9. PubMed ID: 14611674
[TBL] [Abstract][Full Text] [Related]
2. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods.
Shirai T; Sano M; Tamano S; Takahashi S; Hirose M; Futakuchi M; Hasegawa R; Imaida K; Matsumoto K; Wakabayashi K; Sugimura T; Ito N
Cancer Res; 1997 Jan; 57(2):195-8. PubMed ID: 9000552
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate.
Shirai T; Cui L; Takahashi S; Futakuchi M; Asamoto M; Kato K; Ito N
Cancer Lett; 1999 Sep; 143(2):217-21. PubMed ID: 10503907
[TBL] [Abstract][Full Text] [Related]
5. A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP.
Nakagama H; Ochiai M; Ubagai T; Tajima R; Fujiwara K; Sugimura T; Nagao M
Mutat Res; 2002 Sep; 506-507():137-44. PubMed ID: 12351153
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats.
Futakuchi M; Hirose M; Imaida K; Takahashi S; Ogawa K; Asamoto M; Miki T; Shirai T
Carcinogenesis; 2002 Feb; 23(2):283-7. PubMed ID: 11872633
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model.
Borowsky AD; Dingley KH; Ubick E; Turteltaub KW; Cardiff RD; Devere-White R
Neoplasia; 2006 Sep; 8(9):708-15. PubMed ID: 16984728
[TBL] [Abstract][Full Text] [Related]
8. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate.
Nakai Y; Nelson WG; De Marzo AM
Cancer Res; 2007 Feb; 67(3):1378-84. PubMed ID: 17264317
[TBL] [Abstract][Full Text] [Related]
9. Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats.
Tang MX; Ogawa K; Asamoto M; Chewonarin T; Suzuki S; Tanaka T; Shirai T
Nutr Cancer; 2011; 63(2):227-33. PubMed ID: 21298591
[TBL] [Abstract][Full Text] [Related]
10. Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats.
Kühnel D; Taugner F; Scholtka B; Steinberg P
Arch Toxicol; 2009 Aug; 83(8):763-8. PubMed ID: 19212758
[TBL] [Abstract][Full Text] [Related]
11. Equivocal impact of transplacental and lactational exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, on prostate and colon lesion development in F344 rats.
Ikeda Y; Cho YM; Takahashi S; Tang M; Asamoto M; Ogawa K; Shirai T
Cancer Lett; 2005 Jun; 224(1):23-30. PubMed ID: 15911098
[TBL] [Abstract][Full Text] [Related]
12. Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on carcinogenicity in the prostate, colon and pancreas.
Shirai T; Kato K; Futakuchi M; Takahashi S; Suzuki S; Imaida K; Asamoto M
Mutat Res; 2002 Sep; 506-507():129-36. PubMed ID: 12351152
[TBL] [Abstract][Full Text] [Related]
13. Dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced prostate carcinogenesis in CYP1A-humanized mice.
Li G; Wang H; Liu AB; Cheung C; Reuhl KR; Bosland MC; Yang CS
Cancer Prev Res (Phila); 2012 Jul; 5(7):963-72. PubMed ID: 22581815
[TBL] [Abstract][Full Text] [Related]
14. Organ-dependent modifying effects of caffeine, and two naturally occurring antioxidants alpha-tocopherol and n-tritriacontane-16,18-dione, on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary and colonic carcinogenesis in female F344 rats.
Hagiwara A; Boonyaphiphat P; Tanaka H; Kawabe M; Tamano S; Kaneko H; Matsui M; Hirose M; Ito N; Shirai T
Jpn J Cancer Res; 1999 Apr; 90(4):399-405. PubMed ID: 10363577
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinant and environmental carcinogens.
Nagao M; Ochiai M; Ushijima T; Watanabe M; Sugimura T; Nakagama H
Mutat Res; 1998 Jun; 402(1-2):85-91. PubMed ID: 9675250
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5-f]quinoline by dietary indole-3-carbinol in female rats.
He YH; Schut HA
J Biochem Mol Toxicol; 1999; 13(5):239-47. PubMed ID: 10402557
[TBL] [Abstract][Full Text] [Related]
17. Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat.
Guo D; Schut HA; Davis CD; Snyderwine EG; Bailey GS; Dashwood RH
Carcinogenesis; 1995 Dec; 16(12):2931-7. PubMed ID: 8603466
[TBL] [Abstract][Full Text] [Related]
18. Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2'-dimethyl-4-aminobiphenyl.
Shirai T; Nakamura A; Fukushima S; Yamamoto A; Tada M; Ito N
Carcinogenesis; 1990 May; 11(5):793-7. PubMed ID: 2335007
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the susceptibility in rats to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine, PhIP.
Nakagama H; Souda K; Ochiai M; Ishiguro Y; Sugimura T; Nagao M
Cancer Lett; 1999 Sep; 143(2):205-9. PubMed ID: 10503905
[TBL] [Abstract][Full Text] [Related]
20. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility.
Ishiguro Y; Ochiai M; Sugimura T; Nagao M; Nakagama H
Carcinogenesis; 1999 Jun; 20(6):1063-8. PubMed ID: 10357789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
